Characteristics and outcomes of a cohort of COVID-19 patients in the Province of Reggio Emilia, Italy.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 11 05 2020
accepted: 13 08 2020
entrez: 28 8 2020
pubmed: 28 8 2020
medline: 5 9 2020
Statut: epublish

Résumé

This is a population-based prospective cohort study on archive data describing the age- and sex-specific prevalence of COVID-19 and its prognostic factors. All 2653 symptomatic patients tested positive for SARS-CoV-2 from February 27 to April 2, 2020 in the Reggio Emilia province, Italy, were included. COVID-19 cumulative incidence, hospitalization and death rates, and adjusted hazard ratios (HR) with 95% confidence interval (95% CI) were calculated according to sociodemographic and clinical characteristics. Females had higher prevalence of infection than males below age 50 (2.61 vs. 1.84 ‰), but lower in older ages (16.49 vs. 20.86 ‰ over age 80). Case fatality rate reached 20.7% in cases with more than 4 weeks follow up. After adjusting for age and comorbidities, men had a higher risk of hospitalization (HR 1.4 95% CI 1.2 to 1.6) and of death (HR 1.6, 95% CI 1.2 to 2.1). Patients over age 80 compared to age < 50 had HR 7.1 (95% CI 5.4 to 9.3) and HR 27.8 (95% CI 12.5 to 61.7) for hospitalization and death, respectively. Immigrants had a higher risk of hospitalization (HR 1.3, 95% CI 0.99 to 1.81) than Italians and a similar risk of death. Risk of hospitalization and of death were higher in patients with heart failure, arrhythmia, dementia, coronary heart disease, diabetes, and hypertension, while COPD increased the risk of hospitalization (HR 1.9, 95% CI 1.4 to 2.5) but not of death (HR 1.1, 95% CI 0.7 to 1.7). Previous use of ACE inhibitors had no effect on risk of death (HR 0.97, 95% CI 0.69 to 1.34). Identified susceptible populations and fragile patients should be considered when setting priorities in public health planning and clinical decision making.

Identifiants

pubmed: 32853230
doi: 10.1371/journal.pone.0238281
pii: PONE-D-20-13898
pmc: PMC7451640
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0238281

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

JAMA. 2020 Apr 6;:
pubmed: 32250385
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
J Travel Med. 2020 Mar 13;27(2):
pubmed: 32052846
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Diabetes Res Clin Pract. 2020 Jul 22;166:108347
pubmed: 32711003
JAMA. 2020 Mar 23;:
pubmed: 32203977
Lancet Infect Dis. 2020 Jul;20(7):776-777
pubmed: 32224313
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Eur J Epidemiol. 2016 Jul;31(7):691-701
pubmed: 27461270
Int J Infect Dis. 2020 Jun;95:311-315
pubmed: 32234343
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Biology (Basel). 2020 Jul 22;9(8):
pubmed: 32707770
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Aging (Albany NY). 2020 Jul 13;12(13):12493-12503
pubmed: 32658868
Lancet. 2020 Apr 4;395(10230):1110-1111
pubmed: 32220279
J Clin Virol. 2020 Jul;128:104415
pubmed: 32403011
J Infect. 2020 Jun;80(6):639-645
pubmed: 32240670
Allergy. 2020 Jul;75(7):1730-1741
pubmed: 32077115
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
Epidemiol Prev. 2017 May-Aug;41(3-4 (Suppl 1)):1-68
pubmed: 28929718
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143

Auteurs

Paolo Giorgi Rossi (P)

Epidemiology Unit, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Massimiliano Marino (M)

Department of Clinical Governance, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Debora Formisano (D)

Department of Clinical Governance, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Francesco Venturelli (F)

Epidemiology Unit, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.

Massimo Vicentini (M)

Epidemiology Unit, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Roberto Grilli (R)

Department of Clinical Governance, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH